(S)-4-Cyclohexyl-2-(pyridin-2-yl)-4,5-dihydrooxazole, 98% 99%ee, 250mg

tert-Butyl 4-(((4-(4-amino-2-fluorophenoxy)-6-methoxyquinolin-7-yl)oxy)methyl)piperidine-1-carboxylate, 97%, 1g

tert-Butyl 7-benzyl-3,7-diazabicyclo[3.3.1]nonane-3-carboxylate, 95.0%, 5g

Dicyclohexylphosphine oxide, 98%, 5g

METHYL 3-OXOCYCLOPENT-1-ENECARBOXYLATE, 95.0%, 100mg

(2E)-1-(3-bromophenyl)-3-(2-chlorophenyl)prop-2-en-1-one, 95.0%, 2g

N -[3-(2-Amino-thiazol-4-yl)-phenyl]-acetamide, 95+%, 1g

Yohimbine hydrochloride, >99%, 5g

(3-METHYL-[1,2,4]OXADIAZOL-5-YL)-ACETIC ACID, 95.0%, 250mg

(2S)-2-(2,5-Difluorophenyl)-1-[(S)-(1,1-dimethylethyl)sulfinyl]pyrrolidine, 97%, 1g

Radiation protection screen SEKUROKA® hourglass shape With curved base, ? radiation, 1 piece

N,N-Bis(2-chloroethyl)-p-toluenesulfonamide>98.0%(HPLC)(N)25g

2-Nitrophenyl-beta-D-glucopyranoside, min. 99%, for biochemistry, 1 g, glass packaging